Takeda (TAK) director receives 1,800 RSUs and 1,937 tax-linked units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Takeda Pharmaceutical director Kimura Koichiro received new equity-based compensation tied to Ordinary Shares. He was granted 1,800 Ordinary Shares on an award basis at a price of $0.00 per share, bringing his directly held Ordinary Shares to 1,800.
He also received 1,937 units of a Tax Obligation Award, each economically equivalent to one Ordinary Share. According to the disclosure, the 1,800-share award represents restricted stock units that vest on June 1, 2029, while the 1,937-unit Tax Obligation Award will convert to a cash payment at vest primarily to cover tax obligations at the then-current market price.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Kimura Koichiro
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Tax Obligation Award | 1,937 | $0.00 | -- |
| Grant/Award | Ordinary Shares | 1,800 | $0.00 | -- |
Holdings After Transaction:
Tax Obligation Award — 1,937 shares (Direct, null);
Ordinary Shares — 1,800 shares (Direct, null)
Footnotes (1)
- Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest on June 1, 2029. Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Key Figures
RSU grant size: 1,800 shares
RSU grant price: $0.00 per share
Shares held after grant: 1,800 shares
+3 more
6 metrics
RSU grant size
1,800 shares
Ordinary Shares awarded as restricted stock units
RSU grant price
$0.00 per share
Award of Ordinary Shares as compensation
Shares held after grant
1,800 shares
Total non-derivative Ordinary Shares following transaction
Tax Obligation Award units
1,937 units
Economically equivalent to Ordinary Shares
Tax Award exercise/expiration date
June 1, 2029
Exercise and expiration date for Tax Obligation Award units
RSU vesting date
June 1, 2029
Date when RSUs are scheduled to vest
Key Terms
restricted stock units (RSUs), Tax Obligation Award, economic equivalent, Ordinary Shares
4 terms
restricted stock units (RSUs) financial
"Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Tax Obligation Award financial
"Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest"
economic equivalent financial
"Each Tax Obligation Award is the economic equivalent of one Ordinary Share"
FAQ
What did Takeda (TAK) director Kimura Koichiro receive in this Form 4 filing?
Kimura Koichiro received 1,800 Ordinary Shares as an equity award and 1,937 Tax Obligation Award units. Both were granted at a price of zero, reflecting compensation rather than open-market purchases, and are tied to future vesting conditions and tax coverage mechanisms.
When do Kimura Koichiro’s Takeda (TAK) restricted stock units vest?
The restricted stock units granted to Kimura Koichiro vest on June 1, 2029. Each RSU represents a contingent right to receive one Ordinary Share, aligning his compensation with Takeda’s longer-term performance over the period leading up to that vesting date.
What is the Tax Obligation Award reported for Takeda (TAK) director Kimura Koichiro?
The Tax Obligation Award consists of 1,937 units, each economically equivalent to one Ordinary Share. Upon vesting, these units convert into a cash payment primarily to cover tax obligations, using the then-current market price of Takeda’s Ordinary Shares as the valuation basis.